Protease-Defective, gp120-Containing Human Immunodeficiency Virus Type 1 Particles Induce Apoptosis More Efficiently than Does Wild-Type Virus or Recombinant gp120 Protein in Healthy Donor-Derived Peripheral Blood T Cells

Journal of Clinical Microbiology

Volumn 35, Issue 1, 1997, Pages 41-47

  Kameoka, Masanori ^a   Kimura, Takuro ^a   Zheng, Yong Hui ^a   Suzuki, Satoko ^a   Fujinaga, Koh ^a   Luftig, Ronald B ^b   Ikuta, Kazuyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS ENZYME;

APOPTOSIS; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

APOPTOSIS; CELLS, CULTURED; FLOW CYTOMETRY; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VIRION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031059938     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.1.41-47.1997     Document Type: Article

References (29)

1. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
2. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 hy human immunodeficiency-virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-1106.
3. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages hy HIV during the incubation period of AIDS. Nature 362: 359-362.
4. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nature Med. 1:129-134.
5. Foster, S., P. Beverley, and R. Aspinall. 1995. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor. Eur. J. Immunol. 25:1778-1782.
6. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
7. Ikuta, K., C. Morita, S. Miyake, T. Ito, M. Okabayashi, K. Sano, M. Nakai, K. Hirai, and S. Kato. 1989. Expression of human immunodeficiency virus type 1 (HIV-1) gag antigens on the surface of a cell line persistently infected with HIV-1 that highly expresses HIV-1 antigens. Virology 170:408-417.
8. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029-2036.
9. Kishi, M., Y.-H. Zheng, M. K. Bahmani, K. Tokunaga, H. Takahashi, M. Kakinuma, P. K. Lai, M. Nonoyama, R. B. Luftig, and K. Ikuta. 1995. Naturally occurring accessory gene mutations lead to persistent human immunodeficiency virus type 1 infection of CD4-positive T cells. J. Virol. 69:7507-7518.
10. Laurent-Crawford, A. G., B. Krust, S. Muller, Y. Riviere, M.-A. Rey-Cuille, J.-M. Bechet, L. Montagnier, and A. G. Hovanessian. 1991. The cytopathic effect of HIV is associated with apoptosis. Virology 185:829-839.
11. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 tat protein. Science 268:429-131.
12. Luftig, R. B., and K. Ikuta. 1994. Are defective, HIV protease-deficient particles the real culprit in AIDS? A specific type of defective particle produced after persistent infection of lymphoid cells may be the trigger in pathogenesis. ASM News 60:417-419.
13. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16:569-574.
14. Maldarelli, F., H. Sato, E. Berthold, J. Orenstein, and M. A. Martin. 1995. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69:6457-6465.
15. + T cells in vitro. Differential induction of apoptosis in these cells. J. Immunol. 152:330-342.
16. Matsushita, S., M. Robert-Guroff, J. Rusche, A. Koito, T. Hattori, H. Hoshino, K. Javaherian, K. Takatsuki, and S. Putney. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:2107-2114.
17. Nakano, T., K. Sano, T. Goto, S. Morimatsu, S. Ueda, K. Ikuta, S. Kato, and M. Nakai. 1994. Analysis of pol gene of a non-infectious HIV-1 clone, abstr. PA0043. In Proceedings of the 10th International Conference on AIDS and the International Conference on Sexually Transmitted Diseases. Yokohama, Japan.
18. Nakaya, T., K. Fujinaga, M. Kishi, S. Oka, T. Kurata, I. M. Jones, and K. Ikuta. 1994. Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carriers-derived peripheral blood mononuclear cells. FEBS Lett. 354:17-22.
19. Nishino, Y., M. Kishi, M. Sumiya, K. Ogawa, A. Adachi, K. Maotani-Imai, S. Kato, K. Hirai, and K. Ikuta. 1991. Human immunodeficiency virus type 1 vif, vpr, and vpu mutants can produce persistently infected cells. Arch. Virol. 120:181-192.
20. Ohki, K., M. Kishi, Y. Nishino, M. Sumiya, T. Kimura, T. Goto, M. Nakai, and K. Ikuta. 1991. Noninfectious doughnut-shaped human immunodeficiency virus type 1 can induce syncytia mediated by fusion of the particles with CD4-positive cells. J. Acquired Immune Defic. Syndr. 4:1233-1240.
21. Oyaizu, N., T. W. McCloskey, M. Coronesi, N. Chirmule, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3075-3080.
22. Pantaleo, G., C. Graziosi, J. F. Demarest, L. Butini, M. Montroni, C. H. Fox, J. M. Orenstein, D. P. Kotler, and A. S. Fauci. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-358.
23. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
24. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
25. van Noesel, C. J. M., R. A. Gruters, F. G. Terptra, P. T. A. Schellekens, R. A. W. van Lier, and F. Miedema. 1990. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86:293-299.
26. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, H. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.
27. Westendrop, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 tat and gp120. Nature 375:497-500.
28. Yunoki, M., K. Maotani-Imai, H. Kusuda, M. Motoyama, S. Miyake, H. Imai, Y. S. Shin, S. Kato, K. Sano, C. Morita, M. Nakai, K. Hirai, and K. Ikuta. 1991. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1. Arch. Virol. 116:143-158.
29. Zhao, J., N. Araki, and S. K. Nishimoto. 1995. Quantitation of matrix Gla protein mRNA by competitive polymerase chain reaction using glyceraldehyde-3-phosphate dehydrogenase as an internal control. Gene 155:159-165.